Integrated Investment Consultants’s Genmab GMAB Stock Holding History
Bought
Maintained
Sold
Other funds holding GMAB
Integrated Investment Consultants's GMAB Position: Q2 2023 in Review
Integrated Investment Consultants sold out of Genmab (GMAB) in Q2 2023, closing a stake of 13,738 shares — an estimated $519K sold.
Integrated Investment Consultants first reported a position in GMAB in Q2 2020 and held it in 12 quarters. The position peaked at $986K in Q3 2021. 213 funds tracked by Wall St. Rank hold GMAB as of Q2 2023.
- Integrated Investment Consultants reported no remaining Genmab position as of Q2 2023 after selling out during the quarter.
- Integrated Investment Consultants sold 13,738 Genmab shares in Q2 2023, an estimated $519K.
- Integrated Investment Consultants first reported a position in Genmab in Q2 2020 and held it in 12 quarters.
- Integrated Investment Consultants's Genmab position peaked at $986K in Q3 2021.
- 213 funds tracked by Wall St. Rank held Genmab as of Q2 2023.
Based on Integrated Investment Consultants's 13F filing for Q2 2023, filed 18 Jul 2023.